2-(2-((4-Fluorobenzyl)thio)-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl)acetic acid, 97.0%, 5g

4-Methoxypyrazolo[1,5-a]pyridine-3-carboxylic acid, 97.0%, 500mg

n-(2-(1h-Indol-3-yl)ethyl)-2-aminoacetamide, 95%, 1g

3-(2,5-Dimethyl-1h-pyrrol-1-yl)phenol, 95%, 250mg

C -(1,3-Dimethyl-1 H -pyrazol-4-yl)-methylamine, 95.0%, 2.5g

5-(Bromomethyl)-3-(4-methoxyphenyl)-1,2-oxazole, 97%, 250mg

(S)-1-(6-Chloropyridin-3-yl)ethan-1-amine hydrochloride, 97%, 1g

Methyl-beta-cyclodextrin, min. 98%, 5 g, glass packaging

1,3-Diiodo-2-methoxy-5-(trifluoromethyl)benzene, 1g

2-methylpyrido[2,3-d]pyrimidin-4(3H)-one, 95.0%, 1g

Analytical and precision balance Pioneer® series Models with internal adjustment, factory calibrated, 0.0001 g, 220 g, PX224 (W)

2,4-Dichloro-5-iodobenzoic acid, 97%, 5g

5-bromoindole, min. 99.5%, 5 g, glass packaging